Nonsense-mediated mRNA decay: Inter-individual variability and human disease
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Nonsense-Mediated mRNA Decay (NMD) is a regulatory pathway that functions to degrade transcripts containing premature termination codons (PTCs) and to maintain normal transcriptome homeostasis. Nonsense and frameshift mutations that generate PTCs cause approximately one-third of all known human genetic diseases and thus NMD has a potentially important role in human disease. In genetic disorders in which the affected genes carry PTC-generating mutations, NMD acts as a double-edge sword. While it can benefit the patient by degrading PTC-containing mRNAs that encode detrimental, dominant-negative truncated proteins, it can also make the disease worse when a PTC-containing mRNA is degraded that encodes a mutant but still functional protein. There is evidence that the magnitude of NMD varies between individuals, which, in turn, has been shown to correlate with both clinical presentations and the patients’ responses to drugs that promote read-through of PTCs. In this review, we examine the evidence supporting the existence of inter-individual variability in NMD efficiency and discuss the genetic factors that underlie this variability. We propose that inter-individual variability in NMD efficiency is a common phenomenon in human populations and that an individual’s NMD efficiency should be taken into consideration when testing, developing, and making therapeutic decisions for diseases caused by genes harboring PTCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
miRBase: integrating microRNA annotation and deep-sequencing data
Kozomara, A., & Griffiths-Jones, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1027 · Cited by 3,634
Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395 · cited 1×
“This allows functional PTBP2 protein to be made, which in turn activates a cascade of events required for neuronal maturation (Makeyev et al., 2007).”
BackgroundA copy number variation morbidity map of developmental delay
Cooper, G. M., Coe, B. P., Girirajan, S., Rosenfeld, J. A., Vu, T. H., Baker, C., Williams, C., Stalker, H., Hamid, R., Hannig, V., et al. (2011) · Nature Genetics · doi:10.1038/ng.909 · Cited by 1,351
A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes
MacArthur, D. G., Balasubramanian, S., Frankish, A., Huang, N., Morris, J., Walter, K., Jostins, L., Habegger, L., Pickrell, J. K., Montgomery, S. B., et al. (2012) · Science · doi:10.1126/science.1215040 · Cited by 1,272
Nagy, E., & Maquat, L. E. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01208-0 · Cited by 1,187
Regulation of cytoplasmic mRNA decay
Schoenberg, D. R., & Maquat, L. E. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3160 · Cited by 656 · cited 2×
“For a more complete discussion of models of NMD action, see recent reviews (Huang and Wilkinson, 2012; Karam et al., 2013; Nicholson et al., 2010; Schoenberg and Maquat, 2012).”
Experimental strategies for microRNA target identification
Thomson, D. W., Bracken, C. P., & Goodall, G. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr330 · Cited by 544
Gulsuner, S., Walsh, T., Watts, A. C., Lee, M. K., Thornton, A. M., Casadei, S., Rippey, C., Shahin, H., Braff, D., Cadenhead, K. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.049 · Cited by 536 · cited 1×
“Further support for the involvement of NMD in psychiatric disorders comes from the identification of a de novo missense mutation in UPF2 in a patient with schizophrenia, although the functional consequences of the mutation have not been experimentally tested (Gulsuner et al., 2013).”
BackgroundPatterns of Cis Regulatory Variation in Diverse Human Populations
Stranger, B. E., Montgomery, S. B., Dimas, A. S., Parts, L., Stegle, O., Ingle, C. E., Sekowska, M., Smith, G. D., Evans, D., Gutierrez-Arcelus, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002639 · Cited by 470 · cited 6×
“6 Sources of inter-individual variation in NMD efficiency 6.1 Expression quantitative trait loci Expression quantitative trait loci (eQTL) are important factors that contribute to the phenotypic diversity within and among different human population (Dixon et al., 2007; Stranger et al., 2012).”
BackgroundInfluentialYamashita, A., Ohnishi, T., Kashima, I., Taya, Y., & Ohno, S. (2001) · Genes & Development · doi:10.1101/gad.913001 · Cited by 420 · cited 1×
“…NMD genes (SMG8, SMG9 and DHX34) using other methods (Applequist et al., 1997; Denning et al., 2001; Longman et al., 2007; Lykke-Andersen et al., 2000; Mendell et al., 2000; Ohnishi et al., 2003; Perlick et al., 1996; Serin et al., 2001; Yamashita et al., 2009; Yamashita et al., 2001) (Table 1).”
MethodVariation and genetic control of protein abundance in humans
Wu, L., Candille, S. I., Choi, Y., Xie, D., Jiang, L., Li-Pook-Than, J., Tang, H., & Snyder, M. (2013) · Nature · doi:10.1038/nature12223 · Cited by 364
Weischenfeldt, J., Damgaard, I., Bryder, D., Theilgaard-Mönch, K., Thoren, L. A., Nielsen, F. C., Jacobsen, S. E. W., Nerlov, C., & Porse, B. T. (2008) · Genes & Development · doi:10.1101/gad.468808 · Cited by 288 · cited 3×
“Genome-wide analysis of cell lines depleted of NMD factors, as well as NMD-deficient mice, have shown that 3 to 20% of the transcriptome is deregulated as a consequence of compromised NMD (Chan et al., 2009; He et al., 2003; Mendell et al., 2004; Rehwinkel et al., 2005; Tani et al., 2012; Weischenfeldt et al., 2008; W…”
Background(2014) · doi:10.1007/978-1-4614-4788-7 · Cited by 201
Gene expression studies in autism: Moving from the genome to the transcriptome and beyond
Voineagu, I. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.017 · Cited by 72 · cited 2×
“P A A uthor M anuscript (Voineagu, 2012).”
Cited by
Mechanism and regulation of the nonsense-mediated decay pathway
Hug, N., Longman, D., & Cáceres, J. F. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw010 · Cited by 535
“The NMD response has been shown to be variable among different cell-types and tissues (118,119), and even among individuals where this can be correlated with clinical presentations of human diseases caused by the presence of a PTC (13).”
BackgroundCFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Intron retention is a widespread mechanism of tumor-suppressor inactivation
Jung, H., Lee, D., Lee, J., Park, D., Kim, Y. J., Park, W.-Y., Hong, D., Park, P. J., & Lee, E. (2015) · Nature Genetics · doi:10.1038/ng.3414 · Cited by 339
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts
Kingdom, R., & Wright, C. F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.920390 · Cited by 287
microRNA-128a dysregulation in transgenic Huntington’s disease monkeys
Kocerha, J., Xu, Y., Prucha, M. S., Zhao, D., & Chan, A. W. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-46 · Cited by 75
Metadata
- Authors
- Nguyen, L. S., Wilkinson, M. F., & Gecz, J.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 46
- Pages
- 175-186
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2011001112
- Cited by
- 148
- References
- 14
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.